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Abstract: Recent developments in genome sequencing techniques have led to the
identification of huge numbers of endogenous retroviruses (ERV) in various mammals.
ERVs, which occupy 8%–13% of mammalian genomes, are believed to affect mammalian
evolution and biological diversity. Although the functional significance of most ERVs
remains to be elucidated, several ERVs are thought to have pivotal roles in host physiology.
We and other groups recently identified ERV envelope proteins (e.g., Fematrin-1,
Syncytin-Rum1, endogenous Jaagsiekte sheep retrovirus Env) that may determine the
morphogenesis of the unique fused trophoblast cells, termed trinucleate cells and syncytial
plaques, found in ruminant placentas; however, there are still a number of outstanding
issues with regard to the role of ERVs that remain to be resolved. Here, we review what
is known about how these ERVs have contributed to the development of ruminant-specific
trophoblast cells.
Keywords: ruminants; endogenous retrovirus; envelope glycoprotein; fematrin-1;
syncytin-rum1; placenta; cell-to-cell fusion
1. Introduction
Endogenous retroviruses (ERVs) occupy 8%–13% of mammalian genomes, while only 2% of those
genomes are protein-coding genes [1]. “Endogenization” occurs when exogenous retroviruses integrate
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into the genomes of germ cells; these ERVs are then inherited by offspring according to Mendelian
genetics [2]. The detailed mechanism of by which endogenization occurs is not clearly understood, due
to the lack of animal models with which to monitor the endogenization process. As an exceptional case,
Tarlinton et al. reported that the exogenous koala retrovirus (KoRV) is currently colonizing the koala
genome; KoRV is, thus, expected to serve as a good model for understanding endogenization [3]. As with
exogenous retroviruses, proviruses of ERVs consist of gag, pol and env genes flanked by long terminal
repeats (LTRs) at both ends. Most ERVs are considered to be junk DNA, due to the many deletions
and substitutions in their coding sequences; however, recent studies have revealed that several ERVs still
retain intact coding sequences and that the encoded proteins are necessary for their host’s physiology [2].
The placenta is a transient organ that appears only during pregnancy and plays essential roles in
maintaining the fetus throughout gestation. Recent studies have provided us with evidence that ERVs
are involved in placentation in various species [4–12]. In this paper, we review recent findings regarding
ERVs and placentation, especially in ruminants.
2. Diversity of Mammalian Placenta
All placentas consist of fetal trophoblast cells and maternal uterine cells; however, placental
morphologies differ between species [13]. The gross anatomical morphology of the placenta is divided
into four groups: discoidal placenta (e.g., human, mouse), zonary placenta (e.g., cat, dog), cotyledonary
placenta (e.g., cow, sheep) and diffuse placenta (e.g., horse, pig) (Figure 1). Each type of placenta has
a unique microscopic anatomical feature, namely, hemochorial placenta (discoidal), endotheliochorial
placenta (zonary), synepitheliochorial placenta (cotyledonary) and epitheliochorial placenta (diffuse)
(Figure 2). The histological classification is defined by the morphology of the fetomaternal interface
(Table 1).
In both hemochorial and endotheliochorial placentas, the trophoblasts deeply invade maternal tissues
to allow the efficient exchange of nutrients, gases and hormones. They also form specialized cells
called syncytiotrophoblasts, which may prevent rejection of the fetus, the result of maternal immune
responses. Syncytiotrophoblasts are formed by continuous cell-to-cell fusion of cytotrophoblasts.
Maternal endometrial epithelial cells are completely diminished in these placentas (Figure 2).
The most characteristic feature of synepitheliochorial placentas is that they develop only at projections
on the uterine wall, termed caruncles. These placentas are characterized by the presence of about
100 placentomes, which are derived from trophectodermal villi and caruncles, respectively (Figure 1).
In synepitheliochorial placentas, the trophoblast cells do not invade the maternal uterine tissue as
deeply as occurs in hemochorial and endotheliochorial placentas (Figure 2). At the periimplantation
period, the trophoblast cells produce several hormones and proteases that degrade the epithelia of
uterine caruncles [14–16]. The trophectoderm subsequently adheres to the caruncles and develops
the cotyledonary placentomes. The uterine epithelium might be restored after implantation. Some
of the trophectodermal cells, termed trophoblast giant cells or binucleate cells (BNCs), fuse with
the endometrial cells to form fetomaternal hybrid cells throughout the different stages of pregnancy,
including implantation (Figure 2) [17,18]. This fusion is believed to enhance implantation and transport
of various substances [17]. This fetomaternal cell-to-cell fusion is the origin of the term “syn”
epitheliochorial placenta.
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In contrast, no fused cells appear in epitheliochorial placenta and the trophoblasts do not invade
maternal tissues (Figure 2). The fetal and maternal tissues are completely separable in this placenta.
Viruses 2015, 7 3 
 
[17,18]. This fusion is believed to enhance implantation and transport of various substances [17]. This 
fetomaternal cell-to-cell fusion is the origin of the term “syn” epitheliochorial placenta.  
In contrast, no fused cells appear in epitheliochorial placenta and the trophoblasts do not invade 
aternal tissues (Figure 2). The fetal and aternal tissues are co pletely separable in this placenta.  
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Figure 2. Structure of different types of placentas. The fetomaternal interfaces of the placentas 
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3.2. Discovery of Envs Derived from ERVs in Human Placenta
How syncytiotrophoblast morphogenesis occurs was controversial until syncytin-1, the Env of
human endogenous retrovirus (HERV) W at 7q21 (ERVW-1), was reported to be involved in the
process [4,34]. Although other ERVs (e.g., ERV-3) have also been identified as candidates that might
play a role in forming human syncytiotrophoblasts, definitive evidence for their function has not yet
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been established [35–39]. Syncytin-1 is preferentially expressed in placenta, especially cytotrophoblasts
and syncytiotrophoblasts, and has strong fusogenic activity with human trophoblastic cells [4,34].
Syncytin-1 integrated into the common ancestor of hominoids and Old World monkeys (OWMs)
between 20 and 30 million years ago (MYA) [40]. While syncytin-1 is believed to contribute to
syncytiotrophoblast formation in hominoid placenta, it is inactivated in OWMs that are close relatives
of hominoids [40]. Esnault et al. recently suggested that OWMs instead use the EnvV syncytin to
form syncytiotrophoblasts [41]. They showed that both the envV1 and envV2 genes have intact Env
coding sequences in primate genomes; however, only EnvV2 had fusogenicity [41]. Both envV syncytins
were incorporated into the primate genome more than 40 MYA [41]. Even though the envV2 syncytin is
expressed in both OWM and hominoid placenta, the fusogenicity of EnvV2 syncytin has been maintained
only in OWMs and not in hominoids [41]. Thus, hominoids and OWMs utilize different ERV Envs for
syncytiotrophoblast morphogenesis.
After the discovery of syncytin-1, syncytin-2 was identified as another ERV Env that is specifically
expressed in placenta and has fusogenicity [5]. Syncytin-2 appeared in the primate genome more
than 40 MYA, as it is found in most primates except for prosimians [5]. While syncytin-1 is
preferentially expressed in most syncytiotrophoblast cells, syncytin-2 expression is limited to a few
cytotrophoblasts [42,43]. Conversely, the receptors for syncytin-1 (ASCT-2) and syncytin-2 (MFSD2A)
are expressed in cytotrophoblasts and syncytiotrophoblasts, respectively [44,45]. Additionally, the
fusion activity of syncytin-2 appears to be considerably lower than that of syncytin-1 [33]. Therefore,
syncytin-1 and syncytin-2 might have different roles in placentation.
Retroviral Envs also have another important function, namely, immunosuppression. Although
the molecular mechanism is not fully elucidated, the leading model suggests that retrovirus-related
immunosuppression can be attributed to an immunosuppressive domain (ISD) found in TM [46].
ISD function was first confirmed using a synthetic 17 amino acid-long peptide CKS-17
(LQNRRGLDLLFLKEGGL). This peptide sequence is highly conserved in many retroviruses,
including human T-lymphotropic viruses, type C-related HERV, Mason-Pfizer monkey virus, and
Syncytins [33,46,47]. Both syncytin-1 and syncytin-2 have ISD motifs; however, only syncytin-2 was
able to suppress the immune response in vivo, while syncytin-1 was reported to have immunosuppressive
activity in vitro [33,48,49]. This indicates that syncytin-2 might be an essential piece of the strategy that
the placenta adopts to maintain maternal immune tolerance during pregnancy. Taken together, humans
and related species might use syncytin-1/EnvV2 and syncytin-2 mainly for forming syncytiotrophoblasts
and immunosuppression, respectively.
A number of syncytin-like elements have also been identified in additional species, including rodents
(syncytin-A and syncytin-B), lagomorphs (syncytin-Ory1) and carnivores (syncytin-Car1) [7–9]. These
syncytin-like elements are also believed to form syncytiotrophoblasts. More details regarding these
syncytin-like elements are reviewed elsewhere [50].
3.3. ERV Envs Expressed in Ruminant Placenta
Three types of trophoblast cells exist in ruminant placenta: mononucleate trophoblast cells (MTCs),
BNCs and trinucleate cells (TNCs)/syncytial plaques (SyPs) [17]. Although the exact differentiation
process of these cells has not been completely elucidated, a leading model has emerged [18,51]. In
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this model, BNCs appear as the result of MTC endoreduplication, the replication of genomic DNA
without cellular mitosis. The genes for many pregnancy-associated molecules, which have important
roles in maintaining pregnancy, are specifically expressed in BNCs and are modulated by epigenetic
modification [17,51,52]. The BNCs fuse with maternal endometrial cells to efficiently transfer these
molecules to the maternal blood stream [17]. Consequently, fetomaternal hybrid cells appear at the
interface of the fetal and the maternal placentomes (Figure 2) [17]. These hybrid cells are categorized
as TNCs or SyPs, depending on the species (e.g., Bovinae; TNCs, Caprinae; SyPs) [13,53]. TNCs
are composed of a BNC and an endometrial cell, while SyPs are composed of multiple BNCs and
an endometrial cell [17,54]. The population of hybrid cells is small and they disappear by apoptosis
immediately after exocytosis of the pregnancy-associated molecules [17].
For the past decade, it has been suggested that differentiation of ruminant trophoblast cells is driven
by ERVs [9–12,55]. Endogenous Jaagsiekte sheep retroviruses (enJSRVs) are derived from exogenous
JSRV and enzootic nasal tumor virus (ENTV), both of which cause tumors in the ovine respiratory
tract [56–58]. The ovine genome harbors at least 27 enJSRVs and five of them are still intact [57,58].
Some of the enJSRVs are believed to function as restriction factors because they impede the replication
of JSRV and ENTV [59–61]. In addition, env mRNA of enJSRVs named enJS5F16 and enJS56A1 was
detected in the ovine placentome, consisting of BNCs, SyPs, and maternal endometrial tissue [9,62].
Dunlap et al. demonstrated that inhibition of enJSRV Env expression by morpholino antisense oligos
led to death of the conceptus during the periimplantation period due to a failure of BNC development [9].
Even though enJSRV Env is essential for the appearance of BNCs, it remains to be determined whether
it is required for the fetomaternal cell-to-cell fusion found in ovine placenta.
Recently, a large number of bovine endogenous retroviruses (BERVs) were identified by various
sequencing methods [10,63–66]. We searched the bovine genome database to identify potential ERV
Envs, which could play roles in the fetomaternal cell-to-cell fusion. We identified two candidates, named
BERV-K1 and BERV-K2 [10]. Both BERV-K1 and BERV-K2 are categorized as betaretroviruses, which
also include JSRV and mouse mammary tumor virus [10,11]. While the BERV-K2 has all of the coding
sequences including gag, pro-pol and env, BERV-K1 only retains the env coding sequence [10]. We
examined the expression of both BERV-K1 and BERV-K2 env in bovine organs and found that BERV-K1
env but not BERV-K2 env was preferentially expressed in bovine placenta [10,11]. This result was further
supported by in situ hybridization and immunohistochemistry, further demonstrating that BERV-K1 Env
alone was detected specifically in BNCs (Figure 3) [11]. We also conducted in vitro fusion assays using
BERV-K1 Env and primary bovine endometrial cells and found that BERV-K1 Env had high fusogenic
activity [11]. This result suggests that BERV-K1 Env induces fetomaternal cell-to-cell fusion at the
fetomaternal interface. We also conducted fusion assays using BERV-K2 Env; however, BERV-K2 Env
was not able to induce cell-to-cell fusion with endometrial cells [11]. This phenomenon was attributed
to a failure of Env glycoprotein maturation [67].
BERV-K1 is located in intron 18 of the bovine FAT tumor suppressor homolog 2 (bFAT2) gene, which
is highly conserved evolutionarily in eukaryotes [11]. We examined other mammalian species for the
presence of BERV-K1 by genomic PCR and found BERV-K1 in Bovinae (Bos taurus, Bos javanicus,
Bubalus bubalis, and Tragelaphus spekii) but not other species, including Caprinae (Ovis aries, Capra
hircus), human, mouse, dog and cat [11]. From this, we estimate that BERV-K1 infected the common
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ancestor of Bovinae 20 MYA after the separation of Bovinae and Caprinae [11]. Moreover, BERV-K1
shows evidence of purifying selection (dN/dS < 1) [11]. Thus, we suggested that BERV-K1 Env has a
role in forming TNCs in Bovinae placenta, although further studies are required to determine its precise
function in vivo. The BERV-K1 Env was named Fematrin-1 (Fetomaternal trinucleate cell inducer
1) because it is genetically different from syncytins found in the ERVs of other species [11]. We also
found that bFAT2 expression levels were higher in placenta than in other tissues [11]. Additionally, not
only bFAT2 but also ovine FAT2 was preferentially expressed in placenta [11]. This suggests that the
placenta-specific expression of Fematrin-1 is due to its integration into a locus (bFAT2), which has high
transcriptional activity in ruminant placenta.
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Just prior to our publication describing Fematrin-1, Cornelis et al. identified Syncytin-Rum1, also
derived from an ERV Env, as a potential factor involved in fetomaternal cell fusion [12]. Syncytin-Rum1
integration occurred over 30 MYA in the common ancestor of ruminants [12]. Syncytin-Rum1 has
been subjected to purifying selection and is conserved among most ruminants, with the exception
of Tragulidae (mouse-deer), whose ruminant ancestor diverged from the others about 50 MYA [12].
Syncytin-Rum1 is expressed in both bovine and ovine placenta and like Fematrin-1, was specifically
detected in BNCs [12]. Syncytin-Rum1 has the unique characteristic that it is able to exert
fusogenicity only under acidic (pH 5.0) but not neutral (pH 7.0) conditions [12]. Hence, the authors
suggest that the boundary region of the fetomaternal placenta might be of acidic pH [12]. Further
studies regarding whether acidic conditions exist in the ruminant placenta are required to support
this hypothesis. Syncytin-Rum1 transcript levels are higher in ovine placenta than bovine placenta
throughout gestation [12]. This difference in expression levels between sheep and cattle may be one
of the causative agents for the morphological difference in fetomaternal hybrid cells between the two
species [12].
bERVE-A and BERV-P envs have also been identified as transcripts in bovine placenta and
trophectoderm [55,63]. The amino acid sequence of bERVE-A is similar to syncytin-1 and is expressed
preferentially in BNCs [17]. However, bERVE-A might be the result of BNC appearance rather than an
inducer of cell-to-cell fusion because it lacks an intact coding sequence [51]. BERV-P env was identified
in bovine conceptuses, especially trophectoderm, in the periimplantation period [63]. The amino acid
sequence of BERV-P Env is similar to syncytin-Car1 and has both a fusion peptide and an ISD in the TM
subunit [63]. However, the functional significance of these elements has not been determined. Table 2
summarizes the placenta-related endogenous retroviral env genes that have been identified in ruminants
thus far.
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4. Perspective on the Relationship between Fematrin-1 and Syncytin-Rum1
As described above, various mammals utilize at least two ERV Envs to induce cell-to-cell fusion
in their placenta. However, why mammals utilize multiple ERVs in placental development remains
an enigma. Mangeny et al reported that each syncytin has a different primary role, namely either
cell-to-cell fusion or immunosuppression, in both human and mouse placentation [33]. In other words,
syncytin-1 and syncytin-A have higher fusogenic activity than syncytin-2 and syncytin-B, respectively,
while syncytin-2 and syncytin-B have higher immunosuppressive activity [33]. Nakamura and Imakawa
previously proposed the “baton pass” hypothesis, in which the roles of either the original host genes or
older ERVs have been transferred to newer ERVs [68]. For example, in the case of human syncytins,
syncytin-2 probably played roles in both cell-to-cell fusion and immunosuppression at the beginning of
endogenization. However, its fusogenic activity would have been gradually attenuated after syncytin-1
integration and ultimately, the main roles of syncytin-1 and syncytin-2 became distinct.
Likewise, a similar situation might be happening in ruminant placenta, at least in the case of the
Bovinae placenta. Syncytin-Rum1 has both fusogenic and ISD, although the immunosuppressive activity
has not been proved [12]. Moreover, syncytin-Rum1 was incorporated into the ruminant genome
immediately after the appearance of the ruminant ancestor [12]. In contrast, Fematrin-1 does not
contain an ISD, possesses only fusogenic activity and is specific for Bovinae [10,11]. We compared the
fusogenicity of syncytin-Rum1 and Fematrin-1 in neutral acidic conditions and showed that Fematrin-1
possesses higher activity than syncytin-Rum1 [11]. Thus, we propose that the relationship between
syncytin-Rum1 and Fematrin-1 is quite similar to that of human syncytin-1 and syncytin-2: that the role
of syncytin-Rum1 (syncytin-2) in cell-to-cell fusion has been being replaced by Fematrin-1 (syncytin-1)
in Bovinae. Even though no ERVs other than syncytin-Rum1 are known to be involved in cell-to-cell
fusion in other ruminants, some as-of-yet unidentified ERV Env(s) or Fematrin-1 could potentially
replace, or be in the process of replacing, the cell-to-cell fusion function of syncytin-Rum1. This
hypothesis is supported by the observation that syncytin-Rum1 from Giraffidae, Cervidae and some
of Bovidae (especially Antilopini) did not show fusogenicity [12]. This suggests that syncytin-Rum1
contributed, in an evolutionary sense, to the appearance of synepitheliochorial placenta and that
subsequently, newly acquired ERVs, such as Fematrin-1, further engendered morphological variations
in fetomaternal hybrid cells (TNCs or SyPs) in Bovinae. Unfortunately, it is difficult to reproduce such
ERV-driven ruminant placental evolution, due to the lack of animal models. However, we are able to
get an insight into such placental evolution by comparative analysis of ruminant placentas. Tragulidae
species, like the mouse-deer, might be good animals to study ERV-driven ruminant placental evolution,
particularly because their placentas are considered to be a primitive form of the ruminant placenta.
Moreover, they are the unique as ruminants, since they lack syncytin-Rum1 [11,12,69].
It is really interesting that most mammals utilize ERV Envs to form fused cells in placentas even
though the morphology of their placentas differ. Mammals also seem to have evolved the “baton pass” to
employ different ERVs in placentation. This could be considered a kind of convergent evolution among
mammals. Comparative studies and mechanistic investigations into ERV-host co-evolution using animal
models will bring us new insights into various fields, such as virology and evolutional, reproductive and
cell biology.
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